Prospective cohort study consisted of nulliparae giving birth between the 37th and 42nd weeks of singleton low-risk pregnancy, with the fetus in vertex position and without primary indication for CS.
Raw data linked to the manuscript "EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies".
